BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15228186)

  • 21. Disease progression and treatment responses in a prospective DMARD-naive seropositive early rheumatoid arthritis cohort: does gender matter?
    Jawaheer D; Maranian P; Park G; Lahiff M; Amjadi SS; Paulus HE
    J Rheumatol; 2010 Dec; 37(12):2475-85. PubMed ID: 20889597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decrease in bone mineral density during three months after diagnosis of early rheumatoid arthritis measured by digital X-ray radiogrammetry predicts radiographic joint damage after one year.
    Ziegelasch M; Forslind K; Skogh T; Riklund K; Kastbom A; Berglin E
    Arthritis Res Ther; 2017 Sep; 19(1):195. PubMed ID: 28865482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiographic progression is getting milder in patients with early rheumatoid arthritis. Results of 3 cohorts over 5 years.
    Sokka T; Kautiainen H; Häkkinen A; Hannonen P
    J Rheumatol; 2004 Jun; 31(6):1073-82. PubMed ID: 15170917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and Radiographic Outcomes in Patients Diagnosed with Early Rheumatoid Arthritis in the First Years of the Biologic Treatment Era: A 10-year Prospective Observational Study.
    Haugeberg G; Bøyesen P; Helgetveit K; Prøven A
    J Rheumatol; 2015 Dec; 42(12):2279-87. PubMed ID: 26568592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The importance of early treatment for the prognosis of rheumatoid arthritis.
    Kyburz D; Finckh A
    Swiss Med Wkly; 2013; 143():w13865. PubMed ID: 24089023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial.
    Svensson B; Boonen A; Albertsson K; van der Heijde D; Keller C; Hafström I
    Arthritis Rheum; 2005 Nov; 52(11):3360-70. PubMed ID: 16255010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The rheumatoid arthritis patient in the clinic: comparing more than 1,300 consecutive DMARD courses.
    Aletaha D; Smolen JS
    Rheumatology (Oxford); 2002 Dec; 41(12):1367-74. PubMed ID: 12468815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of single time-point damage scores with observed progression of radiographic damage during the first 6 years of rheumatoid arthritis.
    Paulus HE; Oh M; Sharp JT; Gold RH; Wong WK; Park GS; Bulpitt KJ;
    J Rheumatol; 2003 Apr; 30(4):705-13. PubMed ID: 12672187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Course of radiographic damage over 10 years in a cohort with early rheumatoid arthritis.
    Lindqvist E; Jonsson K; Saxne T; Eberhardt K
    Ann Rheum Dis; 2003 Jul; 62(7):611-6. PubMed ID: 12810421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is radiographic progression of late-onset rheumatoid arthritis different from young-onset rheumatoid arthritis? Results from the Swiss prospective observational cohort.
    Mueller RB; Kaegi T; Finckh A; Haile SR; Schulze-Koops H; von Kempis J;
    Rheumatology (Oxford); 2014 Apr; 53(4):671-7. PubMed ID: 24352338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: A meta-analysis.
    Finckh A; Liang MH; van Herckenrode CM; de Pablo P
    Arthritis Rheum; 2006 Dec; 55(6):864-72. PubMed ID: 17139662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Five-year favorable outcome of patients with early rheumatoid arthritis in the 2000s: data from the ESPOIR cohort.
    Combe B; Rincheval N; Benessiano J; Berenbaum F; Cantagrel A; Daurès JP; Dougados M; Fardellone P; Fautrel B; Flipo RM; Goupille P; Guillemin F; Le Loët X; Logeart I; Mariette X; Meyer O; Ravaud P; Saraux A; Schaeverbeke T; Sibilia J
    J Rheumatol; 2013 Oct; 40(10):1650-7. PubMed ID: 23950185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and radiological disease-course in a Swedish DMARD-treated early RA-inception cohort: an observational study.
    Wick MC; Lindblad S; Weiss RJ; Klareskog L; van Vollenhoven RF
    Scand J Rheumatol; 2004; 33(6):380-4. PubMed ID: 15794195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients.
    Humby F; Lewis M; Ramamoorthi N; Hackney JA; Barnes MR; Bombardieri M; Setiadi AF; Kelly S; Bene F; DiCicco M; Riahi S; Rocher V; Ng N; Lazarou I; Hands R; van der Heijde D; Landewé RBM; van der Helm-van Mil A; Cauli A; McInnes I; Buckley CD; Choy EH; Taylor PC; Townsend MJ; Pitzalis C
    Ann Rheum Dis; 2019 Jun; 78(6):761-772. PubMed ID: 30878974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient, disease, and therapy-related factors that influence discontinuation of disease-modifying antirheumatic drugs: a population-based incidence cohort of patients with rheumatoid arthritis.
    Maradit-Kremers H; Nicola PJ; Crowson CS; O'Fallon WM; Gabriel SE
    J Rheumatol; 2006 Feb; 33(2):248-55. PubMed ID: 16358365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of radiographic joint damage in rheumatoid arthritis patients in DAS28 remission using single- or combined with methotrexate non biological disease-modifying antirheumatic drug therapy in routine clinical practice.
    Katayama K; Okubo T; Sato T; Ito H; Fukai R; Baba H
    Mod Rheumatol; 2015 Jan; 25(1):50-5. PubMed ID: 24983407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiological outcome after four years of early versus delayed treatment strategy in patients with recent onset rheumatoid arthritis.
    van Aken J; Lard LR; le Cessie S; Hazes JM; Breedveld FC; Huizinga TW
    Ann Rheum Dis; 2004 Mar; 63(3):274-9. PubMed ID: 14962962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calprotectin (S100A8/A9) and S100A12 are associated with measures of disease activity in a longitudinal study of patients with rheumatoid arthritis treated with infliximab.
    Nordal HH; Brun JG; Hordvik M; Eidsheim M; Jonsson R; Halse AK
    Scand J Rheumatol; 2016 Jul; 45(4):274-81. PubMed ID: 26767827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive factors of 5-year health assessment questionnaire disability in early rheumatoid arthritis.
    Combe B; Cantagrel A; Goupille P; Bozonnat MC; Sibilia J; Eliaou JF; Meyer O; Sany J; Dubois A; Daurès JP; Dougados M
    J Rheumatol; 2003 Nov; 30(11):2344-9. PubMed ID: 14677175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting ultrasound remission in early rheumatoid arthritis: the results of the TaSER study, a randomised clinical trial.
    Dale J; Stirling A; Zhang R; Purves D; Foley J; Sambrook M; Conaghan PG; van der Heijde D; McConnachie A; McInnes IB; Porter D
    Ann Rheum Dis; 2016 Jun; 75(6):1043-50. PubMed ID: 27026689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.